Načítá se...
Insights from the PLCO trial about prostate cancer screening
The potential for prostate-specific antigen (PSA) testing to reduce prostate cancer mortality has been uncertain despite its common use in the United States starting in the early 1990s. Updated results from the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial after a median of 1...
Uloženo v:
| Vydáno v: | Cancer |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5293617/ https://ncbi.nlm.nih.gov/pubmed/27906455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30472 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|